Economy

Trending Stock under Radar: Argos Therapeutics (ARGS)

Shares are clocking price at $0.16 with change of 5.53%. The mean target projections are based on 1 opinions. In contrast to the year ago quarter EPS was at -1.53. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company.

Valuation Ratios of Argos Therapeutics, Inc. The stock now has Weekly Volatility of 12.43% and Monthly Volatility of 8.66%. The latest exchange of 8.56 Million shares is above its average trading activity of 10.24 Million shares.

Argos Therapeutics, Inc. (ARGS) now the company's industry has 31.17 P/E and the sector P/E is 32.99. The average true range (ATR) is a measure of volatility introduced by Welles Wilder. The average analysts gave this company a mean recommendation of 2.80. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock's price, but also to a gradual increase over time.

Argos Therapeutics, Inc. (NASDAQ:ARGS) reported its EPS in the last quarter as $-0.19/Share beating the analyst estimate of $-0.26/Share by a difference of $0.07. For the current year the company's revenue estimates are $380 Million compared to low analyst estimates of $380 Million and high estimates of $380 Million according to the prediction of 1 analysts.

1 number of analysts have estimated the sales of the company for the quarter ending Mar 30, 2017- Mar 31, 2017, analysts estimated mean sale target of 0.38 million while high and low sale targets are estimated at 0.38 million and 0.38 million respectively.

Currently Argos Therapeutics (NASDAQ:ARGS)'s shares owned by insiders are 3.8%, whereas shares owned by institutional owners are 9.4%.

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -82.31%, and has a solid year to date (YTD) performance of -96.94% which means that the stock is constantly adding to its value from the previous fiscal year end price.

Argos Therapeutics, Inc. (NASDAQ:ARGS) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. Its book value per share for the most recent quarter is $-0.5 while its price to book ratio for the same period is 0, as for as the company's cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock touched 52-week High of $5.68 on 01/09/17 and 52-week Low of $0.13 on 11/02/17.

Tesla, Inc. (NASDAQ:TSLA), stock is trading $389.61 above the 52-week high and has displayed a high EPS growth of -13.10% in last 5 years.



Like this

Latest


09 November 2017
April the giraffe may be pregnant AGAIN — GMA reveal
The owner of Animal Adventure Park in NY said on Good Morning America that he "can't confirm nor deny" the possibility of April being pregnant again.

09 November 2017
Stock Review: Checking in on the Levels for Cheetah Mobile Inc (CMCM)
California-based Reilly Fincl Advisors Ltd Limited Liability Company has invested 0% in Tortoise Energy Infrastructure Corp. Over the last three months, the shares of the company have changed -18.00% and performed -20.11% over the last six months.

09 November 2017
Tiaa Fsb Cuts Position in Accenture PLC
Clearbridge Ltd Liability Com stated it has 0% of its portfolio in Superior Energy Services, Inc. (NYSE:SPN) for 81,810 shares. The company has its outstanding shares of 638.37M. 1,400 were reported by Cubist Systematic Strategies Ltd Com. (NYSE:SPN).

09 November 2017
Constellation Brands Inc (STZ) Shares Bought by OLD National Bancorp IN
Ltd. now owns 780 shares of the company's stock worth $151,000 after acquiring an additional 670 shares during the last quarter. It fall, as 45 investors sold OCLR shares while 58 reduced holdings. 108 funds opened positions while 221 raised stakes.

09 November 2017
Four Russian skiers get life ban from Olympics over alleged doping use
Vylegzhanin won three silver medals during the Sochi Olympics, while three other athletes finished the Games without a medal. Legkov, in his first public comments since being banned, wrote on his Instagram page late on Monday: "My medal is clean".

09 November 2017
Stock Moving Up in Today's Session: NGL Energy Partners LP(NYSE:NGL)
BidaskClub lowered shares of Ngl Energy Partners Lp from a sell rating to a strong sell rating in a report on Thursday, July 27th. Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates.

09 November 2017
Analyzing the Financial Health of Schlumberger Limited (NYSE:SLB)
On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. With 2.13 million avg volume, 1 days are for Gevo Incorporated (NASDAQ:GEVO)'s short sellers to cover GEVO's short positions.

09 November 2017
Trump's Voter Fraud Commission Is Being Sued by One of Its Commissioners
According to the press release, Dunlap's suit is based on the 1999 Washington, D.C. federal Circuit Court decision in Cummock v. The panel was rattled last month by the arrest of a staff member on charges of possessing child pornography.

09 November 2017
Look out for Bangladeshis in Paradise Papers
The CPI expressed its disappointment with the probe and said that "even after 18 months no progress has been made". Its predecessor, the Panama Papers, allegedly revealed the names of some Bangladeshi businessmen and politicians.

09 November 2017
Microsoft introduces new secure firmware spec via the Open Compute Project
Project Olympus hardware is now deployed in volume production with the Fv2 virtual machine (VM) family . Microsoft meanwhile has also turned its attention to platform security with "Project Cerberus".



Recommended